Change Language
Bosutinib Tablets

Bosutinib Tablets

Product Details:

  • Physical Form Tablets
  • Dosage 400 mg
  • Dosage Guidelines As per physician
  • Storage Instructions Keep dry & cool place
  • Click to View more

Bosutinib Tablets Price And Quantity

  • 5 Pack

Bosutinib Tablets Product Specifications

  • 400 mg
  • Tablets
  • As per physician
  • Keep dry & cool place

Bosutinib Tablets Trade Information

  • Cash Advance (CA) Cash in Advance (CID)
  • 1000 Pack Per Week
  • 4 Days
  • All India South India Central India West India North India East India Gujarat Karnataka Kerala Lakshadweep Mizoram Meghalaya Manipur Andhra Pradesh Bihar Chandigarh Daman and Diu Goa Jharkhand Odisha Punjab Assam Delhi Dadra and Nagar Haveli Andaman and Nicobar Islands Arunachal Pradesh Chhattisgarh Haryana Himachal Pradesh Jammu and Kashmir Madhya Pradesh Maharashtra Nagaland Rajasthan Sikkim Tamil Nadu Telangana Tripura Pondicherry Uttar Pradesh Uttarakhand West Bengal

Product Description

Bosutris 400 Tablet is an anti-cancer medicine. It isïused in the treatment of certain blood cancer known as chronic myeloid leukemia. This medicine helps to slow down the growth and multiplication of cancer cells, thereby reducing the progress of the disease. Netupitant 300 mq & Palonosetron 0.5 mg Capsule Akynzeo Oral use 1x1capsule

  1. What is Bosutinib?

    • Bosutinib is a medication used in the treatment of chronic myeloid leukemia (CML), a type of cancer that affects the blood and bone marrow.
  2. How does Bosutinib work?

    • Bosutinib is a tyrosine kinase inhibitor, which means it works by blocking the activity of certain proteins (tyrosine kinases) that are involved in the growth and survival of cancer cells. By inhibiting these proteins, bosutinib helps to slow down or stop the progression of CML.
  3. What are the common side effects of Bosutinib?

    • Common side effects of bosutinib may include diarrhea, nausea, abdominal pain, vomiting, rash, fatigue, headache, and low blood cell counts (anemia, neutropenia, thrombocytopenia).
  4. How is Bosutinib taken?

    • Bosutinib is usually taken by mouth in the form of tablets, once daily with food. The dosage and treatment duration may vary depending on the individual's condition and response to therapy. It's essential to follow the dosing instructions provided by your healthcare provider.
  5. Who can take Bosutinib?

    • Bosutinib is indicated for the treatment of adults with newly diagnosed chronic phase CML as well as those with CML that is resistant or intolerant to prior therapy, including imatinib.
  6. Are there any precautions or contraindications for using Bosutinib?

    • Bosutinib may not be suitable for individuals with certain pre-existing medical conditions, such as liver or kidney problems. It may also interact with other medications, so it's important to inform your healthcare provider about all medications you are taking. Pregnant or breastfeeding women should discuss the risks and benefits of bosutinib with their healthcare provider.
  7. How effective is Bosutinib in treating chronic myeloid leukemia?

    • Bosutinib has been shown to be effective in the treatment of chronic phase CML, both in newly diagnosed patients and those who have developed resistance or intolerance to prior therapy. Clinical trials have demonstrated its ability to induce and maintain hematologic and cytogenetic responses in patients with CML.
  8. What should I do if I miss a dose of Bosutinib?

    • If you miss a dose of bosutinib, take it as soon as you remember, unless it is almost time for your next dose. In that case, skip the missed dose and take your next dose at the regular time. Do not take two doses at once to make up for a missed dose.
  9. Are there any long-term effects or risks associated with Bosutinib treatment?

    • Long-term effects of bosutinib treatment may include cardiovascular events, liver toxicity, and gastrointestinal issues. Regular monitoring by healthcare professionals is necessary to manage and mitigate potential long-term effects and risks associated with bosutinib therapy.
  10. Where can I find more information about Bosutinib tablets?

    • Additional information about bosutinib, including its mechanism of action, clinical trials, and prescribing information, can be obtained from your healthcare provider or the manufacturer's website. Patient advocacy organizations and support groups may also offer resources and support for individuals undergoing treatment for chronic myeloid leukemia.

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Anti Cancer Medicines' category

Back to top